Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.8
-201.95%
20%
—
76x
Every year
—
5 Years
Score3.8
Net Growth-201.95%
Net Trend20%
Net Income Consistency—
Rev Growth76x
Rev TrendEvery year
Revenue Consistency—
Rhythm Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 35K to $ 189M and net income went from -$ 130M to -$ 196M. Revenue increased in every one of those 5 years; net income in 1.
Rhythm Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 117.60 | — |
1 Year2025-08-12 | $ 96.46 | 21.92% |
5 Years2021-08-12 | $ 14.23 | 8x |
All Time2017-10-05 | $ 30.00 | 292.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-10-05 |
|---|---|---|---|---|
| Price | $ 117.60 | $ 96.46 | $ 14.23 | $ 30.00 |
| Return | — | 21.92% | 8x | 292.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 239M | -$ 205M | $ 330M |
| 2025 | $ 189M | -$ 196M | $ 388M |
| 2024 | $ 130M | -$ 260M | $ 320M |
| 2023 | $ 77M | -$ 184M | $ 275M |
| 2022 | $ 23M | -$ 181M | $ 333M |
| 2021 | $ 3M | -$ 68M | $ 294M |
| 2020 | $ 35K | -$ 130M | $ 172M |
| 2019 | $ 0.00 | -$ 134M | $ 292M |
| 2018 | $ 0.00 | -$ 74M | $ 252M |
| IPO2017 | $ 0.00 | -$ 33M | $ 148M |
Explore beyond RYTM
You're looking at Rhythm Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
